Filing Details
- Accession Number:
- 0001387131-14-000477
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-12 19:07:04
- Reporting Period:
- 2014-02-10
- Filing Date:
- 2014-02-12
- Accepted Time:
- 2014-02-12 19:07:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
25743 | Therapeuticsmd Inc. | TXMD | Pharmaceutical Preparations (2834) | 870233535 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1532232 | Mitchell Krassan | 6800 Broken Sound Parkway Nw 3Rd Floor Boca Raton FL 33487 | Evp, Chief Strategy Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-02-10 | 7,500 | $0.19 | 7,500 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-02-10 | 7,500 | $6.34 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-02-10 | 7,500 | $0.00 | 7,500 | $0.19 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
150,703 | 2011-10-04 | 2020-05-01 | No | 4 | M | Direct |
Footnotes
- The shares were sold pursuant to a 10b5-1 Sales Plan dated December 9, 2013.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.28 to $6.41, inclusive. The reporting person undertakes to provide TherapeuticsMD, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.